Joachim Ermer Overview:
Statistical Process Control (SPC) is a method of monitoring, controlling, and improving processes through the use of statistical techniques. SPC is a contribution to maintain product quality, increase efficiency, reduce waste, and identify areas that need improvement. In pharmaceutical manufacturing, it is a regulatory requirement to establish an “An ongoing program to collect and analyze product and process data that relate to product quality must be established (§ 211.180(e)). The data should be statistically trended and reviewed by trained personnel. should verify that the quality attributes are being appropriately controlled throughout the process.” (FDA Guidance for Industry: Process Validation: General Principles and Practices (2011)).
Why you should Attend:
Participants will get an overview on the statistical basis for SPC, i.e. the distribution of data. This will be illustrated in detail by the commonly expected normal (Gaussian) distribution. Such common cause variation is inherent to the process and is typically stable over time. The other type of variation is called special cause variation, or systematic bias. SPC aims to distinguish between these two types of variation so that appropriate actions can be taken. By using SPC tools, problems can be detected early, variations in product quality reduced, and continual improvements achieved.
Participants will learn about the so-called “magnificent seven” SPC tools histograms, check sheets, pareto charts, cause-and-effect diagrams, defect concentration diagrams, scatter diagrams, and control charts. For the latter, a general introduction will be provided, with more detailed information on various types of control charts in a separate Webinar.
Areas Covered in the Session:
Who Will Benefit:
Dr. Joachim Ermer is a biochemist with 30 years of experience in pharmaceutical analytics, including development products at Hoechst AG, global responsibilities as Director of Analytical Processes and Technology at Aventis, and head of Quality Control and head of QC Lifecycle Management Frankfurt Chemistry at Sanofi. Since December 2020, he serves as consultant for topics of pharmaceutical analytics and Quality Control. Joachim Ermer is member of the USP Expert Committee “Measurement and Data Quality“, of the Ph.Eur. Working Group “Chromatographic Separation Techniques”, and Advisory Board member of the ECA Analytical Quality Control Group.
He authored more than 60 publications on analytical topics and contributed to the USP General Information Chapter <1220> as well as other Stimuli Articles. He is editor and author of the book “Method Validation in Pharmaceutical Analysis. A Guide to Best Practice” (Wiley-VCH, 2005, 2015, 2024).